ロード中...
Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity
As the leading cause of cancer-related death, hepatocellular carcinoma (HCC) threatens human health and limited treatments are available to cure the disease efficiently and effectively. The particularly immunotolerant environment of the liver lowers the efficacy of current therapies in patients with...
保存先:
| 出版年: | Evid Based Complement Alternat Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305542/ https://ncbi.nlm.nih.gov/pubmed/32595757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9843486 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|